MRI from Picture to Proton presents the basics of MR practice and theory in a unique way: backwards! The subject is approached just as a new MR practitioner would encounter MRI: starting from the images, equipment and scanning protocols, rather than pages of physics theory. The reader is brought face-to-face with issues pertinent to practice immediately, filling in the theoretical background as their experience of scanning grows. Key ideas are introduced in an intuitive manner which is faithful to the underlying physics but avoids the need for difficult or distracting mathematics. Additional explanations for the more technically inquisitive are given in optional secondary text boxes. The new edition is fully up-dated to reflect the most recent advances, and includes a new chapter on parallel imaging. Informal in style and informed in content, written by recognized effective communicators of MR, this is an essential text for the student of MR.

Quantitative susceptibility mapping (QSM) has enabled MRI of tissue magnetic susceptibility to advance from simple qualitative detection of hypointense blooming artifacts to precise quantitative measurement of spatial biodistributions. QSM technology may be regarded to be sufficiently developed and validated to warrant wide dissemination for clinical applications of imaging isotropic susceptibility, which is dominated by metals in tissue, including iron and calcium. These biometals are highly regulated as vital participants in normal cellular biochemistry, and their dysregulations are manifested in a variety of pathologic processes. Therefore, QSM can be used to assess important tissue functions and disease. To facilitate QSM clinical translation, this review aims to organize pertinent information for implementing a robust automated QSM technique in routine MRI practice and to summarize available knowledge on diseases for which QSM can be used to improve patient care. In brief, QSM can be generated with postprocessing whenever gradient echo MRI is performed. QSM can be useful for diseases that involve neurodegeneration, inflammation, hemorrhage, abnormal oxygen consumption, substantial alterations in highly paramagnetic cellular iron, bone mineralization, or pathologic calcification; and for all disorders in which MRI diagnosis or surveillance requires contrast agent injection. Clinicians may consider integrating QSM into their routine imaging practices by including gradient echo sequences in all relevant MRI protocols.

Purpose Venous blood oxygen saturation is an indicator of brain oxygen consumption and can be measured directly from quantitative susceptibility mapping (QSM) by deconvolving the MR phase signal. However, accurate estimation of the susceptibility of blood may be affected by flow induced phase in the presence of imaging gradient and the inhomogeneous susceptibility field gradient. The purpose of this study is to correct the flow induced error in QSM for improved venous oxygenation quantification. Methods Flow compensation is proposed for QSM by using a fully flow compensated multi-echo gradient echo sequence for data acquisition. A quadratic fit of the phase with respect to echo time is employed for the flow phase in the presence of inhomogeneity field gradients. Phantom and in vivo experiments were carried out to validate the proposed method. Results Phantom experiments demonstrated reduced error in the estimated field map and susceptibility map. Initial data in in vivo human imaging demonstrated improvements in the quantitative susceptibility map and in the estimated venous oxygen saturation values. Conclusion Flow compensated multi-echo acquisition and an adaptive-quadratic fit of the phase images improves the quantitative susceptibility map of blood flow. The improved vein susceptibility enables in vivo measurement of venous oxygen saturation throughout the brain.

I n the 30 years since gadolinium-based contrast agents (GBCAs) were first introduced to enhance MRI (1), their adoption into routine clinical practice has been prolific. Worldwide, more than 450 million doses of GBCAs have been administered and have yielded indispensable diagnostic information in virtually every organ system (2). The safety profile of GBCAs was relatively unblemished until their association with nephrogenic systemic fibrosis in 2006 (3). Clinical practice patterns were altered rapidly, and judicious use or avoidance of GBCAs in patients with

Purpose: To develop quantitative susceptibility mapping (QSM) of bone using an ultrashort echo time (UTE) gradient echo (GRE) sequence for signal acquisition and a bonespecific effective transverse relaxation rate (R Ã 2 ) to model water-fat MR signals for field mapping. Methods: Three-dimensional radial UTE data (echo times ! 40 ms) was acquired on a 3 Tesla scanner and fitted with a bone-specific signal model to map the chemical species and susceptibility field. Experiments were performed ex vivo on a porcine hoof and in vivo on healthy human subjects (n ¼ 7). For water-fat separation, a bone-specific model assigning R Ã 2 decay mostly to water was compared with the standard models that assigned the same decay for both fat and water. In the ex vivo experiment, bone QSM was correlated with CT. Results: Compared with standard models, the bone-specific R Ã 2 method significantly reduced errors in the fat fraction within the cortical bone in all tested data sets, leading to reduced artifacts in QSM. Good correlation was found between bone CT and QSM values in the porcine hoof (R 2 ¼ 0.77). Bone QSM was successfully generated in all subjects. Conclusions: The QSM of bone is feasible using UTE with a conventional echo time GRE acquisition and a bone-specific R